Elevated levels of Aβ have been suggested to be caused by genetic mutations in the genes for amyloid precursor protein (APP), presenilin 1 (PS1), and presenilin 2 (PS2) as early onset and familial forms of AD have been associated with mutations in these genes [6,7,8]. This evidence concerns the gene APP and Alzheimer disease.